Voyager Therapeutics Prices Public Offering Of 7,777,778 Common Shares At $9/Share
Portfolio Pulse from Benzinga Newsdesk
Voyager Therapeutics has priced an underwritten public offering of 7,777,778 common shares at $9 each and pre-funded warrants for 3,333,333 shares at $8.999 each, aiming to raise approximately $100 million before fees and expenses. All securities are sold by the company.
January 05, 2024 | 6:28 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Voyager Therapeutics is raising approximately $100 million through a public offering of shares and pre-funded warrants, which may dilute current shareholders but provide capital for operations and growth.
The public offering of additional shares and warrants by Voyager Therapeutics is likely to have a dilutive effect on existing shareholders in the short term, which could lead to a negative impact on the stock price. However, the infusion of capital is critical for the company's operations and future growth, which may be viewed positively in the long term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100